Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes
in patients with relapsed/refractory multiple myeloma
京都府立医科大学 古林 勉 Int J Hematol. 2015 Jan;101(1):37-45.
![](https://myeloma.jp/wp-content/themes/cocoon-master/screenshot.jpg)
Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes
in patients with relapsed/refractory multiple myeloma